Cocrystal Pharma (COCP) Q1 2026 Annual Earnings
COCP·Reported May 15, 2026·Before market open
Cocrystal Pharma reported Q1 2026 revenue of $225.0K. Diluted EPS came in at $-0.17 (+26.1% YoY), missed the $-0.15 consensus by $0.02.
Revenue
$225.0Kmet estimate
Consensus: $225.0KDiluted EPS
$-0.17missed by $0.02
Consensus: $-0.15
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Cocrystal Pharma's Q1 2026 earnings report.
Cocrystal Pharma (COCP) reported Q1 2026 earnings on May 15, 2026 before market open.
Cocrystal Pharma reported revenue of $225.0K and diluted EPS of $-0.17 for Q1 2026.
Revenue beat the consensus estimate of $225.0K by -. EPS missed the consensus estimate of $-0.15 by $0.02.
Compared to the same quarter a year prior, diluted EPS grew 26.1% from $-0.23.
You can read the 10-K periodic report (0001493152-26-013838) directly on SEC EDGAR. The filing index links above go to sec.gov.